HSA

HSA  

 

GHSA-125, 12 x 5 ml

Indications for Use   For use as a protein supplement for culture media and other solutions that are used in assisted reproductive procedures.
     
Storage and Shelf Life   Store at 2-8°C and protected from light. One (1) year from the date of manufacture.
     
Composition   HSA consists of human serum albumin from therapeutic-grad source material, as a concentration of 100 mg/ml in a sterile saline solution.
     
Recommendations for Use   For a full and detailed recommended protocol of use for HSA please contact us at customerservice@lifeglobal.com.

     
Quality Control Specifications  
Assay (performed for each batch) Specification
pH 7.2-7.4
Osmolality 265-285 mOsM
Endotoxin (LAL) < 1.0 EU/ml
Sterility Test (bacterial and fungal screen, SAL 10–3) PASS
1-cell Mouse Embryo Assay (% expanded blastocysts at 96 h of culture) > 80%
     
Precautions and Warnings  
  1. Caution: Federal Law (USA) restricts this device to sale by or on the order of a physician (or properly licensed practitioner).
  2. Caution: The user should read and understand the Instructions for Use, Precautions and Warnings, and be trained in the correct procedure before using HSA for use as a protein supplement for culture media and other solutions that are used in assisted reproductive procedures.
  3. Not to be used for injection.
  4. Do not resterilize.
  5. Do not use the product if:
    • the product packaging appears damaged or if the seal is broken
    • the expiry date has been exceeded
    • the product becomes discolored, cloudy, or shows evidence of particulate matter
  6. This product contains human serum albumin, a derivative of human blood. The human serum albumin used in the preparation of this product has been heated at 60°C for ten hours.
    Caution: Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses. Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. This also applies to unknown or emerging viruses and other pathogens. There are no reports of virus transmissions with albumin manufactured to European Pharmacopoeia specifications by established processes. It is strongly recommended that every time that HSA is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.
  7. To avoid problems with contamination, practice aseptic techniques.
  8. Each vial of HSA is intended for single use only. Discard any unused product after opening.